Edition:
United Kingdom

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

924.10INR
19 Jan 2018
Change (% chg)

Rs3.05 (+0.33%)
Prev Close
Rs921.05
Open
Rs925.00
Day's High
Rs926.00
Day's Low
Rs906.40
Volume
1,343,268
Avg. Vol
2,101,348
52-wk High
Rs1,573.60
52-wk Low
Rs806.25

Chart for

About

Lupin Limited is a pharmaceutical company. The Company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world. The Company offers products in the cardiovascular, diabetology, asthma, pediatrics, central... (more)

Overall

Beta: -0.05
Market Cap(Mil.): Rs469,414.59
Shares Outstanding(Mil.): 451.84
Dividend: 7.50
Yield (%): 0.72

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Lupin Launches Generic Vibra-Tabs Tablet In U.S.

* DRUG INDICATED IN TREATMENT OF INFECTIONS CAUSED BY VARIOUS MICROORGANISMS AND AS AN ADJUNCTIVE THERAPY IN SEVERE ACNE Source text - http://bit.ly/2mVrrgE Further company coverage:

19 Jan 2018

BRIEF-Lupin Announces Pan-India Launch Of Softovac

* SAYS CO FORAYS INTO OVER-THE-COUNTER SEGMENT WITH PAN-INDIA LAUNCH OF SOFTOVAC Source text - http://bit.ly/2mGumd7 Further company coverage:

15 Jan 2018

BRIEF-Lupin Gets FDA Approval For Generic Tamiflu Capsules

* LUPIN - GETS FDA APPROVAL FOR GENERIC TAMIFLU CAPSULES Source text: (http://bit.ly/2Fn4vPg) Further company coverage:

10 Jan 2018

BRIEF-Lupin Launches Generic Ancobon Capsules In U.S.

* SAYS LAUNCHES GENERIC ANCOBON CAPSULES IN U.S. Source text for Eikon: Further company coverage:

05 Jan 2018

BRIEF-Lupin Gets FDA Approval For Generic Dovonex Scalp Solution

* GETS FDA APPROVAL FOR GENERIC DOVONEX SCALP SOLUTION Source text: (http://bit.ly/2lbGh1I) Further company coverage:

28 Dec 2017

BRIEF-Lupin Gets U.S. FDA Nod For Generic Contraceptive Treatment

* SAYS LUPIN RECEIVES FDA APPROVAL FOR GENERIC SAFYRAL TABLETS

14 Dec 2017

Yes Bank, IndusInd to join India's BSE Sensex index; Lupin, Cipla dropped

Nov 17 Indian private sector lenders Yes Bank Ltd and IndusInd Bank Ltd will join the BSE stock exchange's 30-member Sensex index, effective Dec. 18, the index provider said on Friday.

17 Nov 2017

BRIEF-Lupin launches generic Acticlate tablets in U.S.‍​

* Says co launches generic Acticlate tablets in U.S.‍​ Source text: http://bit.ly/2ypyZzY Further company coverage:

02 Nov 2017

UPDATE 1-India's Lupin Q2 profit falls on lower U.S. sales, but beats estimates

* U.S. sales down 32 pct (Recasts, adds details, bullets, share moves)

30 Oct 2017

BRIEF-Lupin says co on track with complex generic pipeline

* Says as expected, co continues to see pricing pressure for its U.S. generic business

30 Oct 2017

Earnings vs. Estimates